Gorana Matovina Brko, Maja Popovic, Masa Jovic, Jelena Radic, Milka Bodlovic Kladar, Ivan Nikolic, Vladimir Vidovic, Ivana Kolarov Bjelobrk, Biljana Kukic, Svetlana Salma, Jelena Litavski, Nemanja Petrovic, Bojana Vranjkovic, Tatjana Roganovic, Maja Ruzic, Tihomir Dugandzija, Lazar Popovic
PURPOSE: Recommendations and guidelines consider cancer patients a high-priority population for COVID-19 immunization. Vaccination process in Serbia began in January 2021 with four available vaccines. We have conducted a cross-sectional study investigating cancer patients' acceptability of anti SARS-COV2 vaccines. METHODS: The study included 767 patients with solid and hematologic malignancies treated at the Oncology Institute of Vojvodina, Serbia. During July and August 2021 patients filled in an individual paper questionnaire on anti SARS-COV2 vaccination acceptance, preferences, side effects and information origin...
September 2021: Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology